Growth Metrics

Volitionrx (VNRX) Other Non-Current Liabilities (2011 - 2025)

Volitionrx posted quarterly Other Non-Current Liabilities of $112770.0 for Q3 2025, down 19.8% on a QoQ basis from $140612.0 in Q2 2025.

Volitionrx (VNRX) has 14 years of Other Non-Current Liabilities data on file, last reported at $112770.0 in Q3 2025.

  • For the quarter ending Q3 2025, Other Non-Current Liabilities changed N/A year-over-year to $112770.0; the trailing twelve-month figure through Sep 2025 stood at $112770.0 (changed N/A YoY), and the FY2023 full-year result was $126649.0, down 69.88% from the prior year.
  • Other Non-Current Liabilities for Q3 2025 stood at $112770.0, down from $140612.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $432486.0 in Q3 2023 and bottomed at $77848.0 in Q1 2025.
  • The 4-year median for Other Non-Current Liabilities is $253221.0 (2021), against an average of $270097.5.
  • Peak annual rise in Other Non-Current Liabilities reached 106.85% in 2023, while the deepest fall reached 69.88% in 2023.
  • A 4-year view of Other Non-Current Liabilities shows it stood at $253221.0 in 2021, then soared by 66.05% to $420466.0 in 2022, then sank by 69.88% to $126649.0 in 2023, then fell by 10.96% to $112770.0 in 2025.
  • The last three Other Non-Current Liabilities figures came in at $112770.0 (Q3 2025), $140612.0 (Q2 2025), and $77848.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Volitionrx 101.83 Mn 99.36 Mn -1.01 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 112,770.00
Jun 30, 2025 140,612.00
Mar 31, 2025 77,848.00
Dec 31, 2023 126,649.00
Sep 30, 2023 432,486.00
Jun 30, 2023 427,732.00
Mar 31, 2023 425,951.00
Dec 31, 2022 420,466.00
Sep 30, 2022 390,709.00
Jun 30, 2022 206,785.00
Mar 31, 2022 246,970.00
Dec 31, 2021 253,221.00
Sep 30, 2021 266,813.00
Jun 30, 2021 273,138.00
Mar 31, 2021 249,313.00
Dec 31, 2020 259,603.00
Sep 30, 2020 277,267.00
Jun 30, 2020 302,106.00
Mar 31, 2020 296,431.00
Dec 31, 2019 297,991.00
Sep 30, 2019 289,492.00
Mar 31, 2019 337,096.00
Dec 31, 2018 311,042.00
Sep 30, 2018 317,731.00
Jun 30, 2018 143,100.00
Mar 31, 2018 194,030.00
Dec 31, 2017 188,579.00
Sep 30, 2017 185,991.00
Jun 30, 2017 179,800.00
Mar 31, 2017 205,520.00
Dec 31, 2016 202,325.00
Sep 30, 2016 215,697.00
Jun 30, 2016 213,644.00
Mar 31, 2016 258,226.00
Dec 31, 2015 248,009.00
Sep 30, 2015 255,673.00
Jun 30, 2015 252,284.00
Mar 31, 2015 281,456.00
Dec 31, 2014 351,773.00
Sep 30, 2014 367,112.00
Jun 30, 2014 429,007.00
Mar 31, 2014 432,371.00
Dec 31, 2013 432,811.00
Sep 30, 2013 1.28 Mn
Jun 30, 2013 1.14 Mn
Mar 31, 2013 616,023.00
Dec 31, 2012 635,201.00
Sep 30, 2012 617,897.00
Jun 30, 2012 604,487.00
Dec 31, 2011 621,935.00